Company Profile

XL Sci-Tech Inc
Profile last edited on: 4/24/25      CAGE: 3E6N4      UEI: H1Z8MEH658H9

Business Identifier: Speciality materials R&D firm capable of manuf----acturing precision and multi-function microspheres and nanospheres in large quantities
Year Founded
1995
First Award
1995
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3100 George Washington Way
Richland, WA 99354
   (509) 375-0884
   info@xlscitech.com
   www.xlscitech.com
Location: Single
Congr. District: 04
County: Benton

Public Profile

Founded by a core team of scientists through an Entrepreneur Leave of Absence program from US Department of Energy's Pacific Northwest National Laboratory (PNNL), XL Sci-Tech Inc is a specialty materials R&D firm capable of manufacturing precision and multi-function microspheres and nano-spheres in large quantities. Under development by the firm's personnel are new materials for use in repairing broken bones and other bone defects. Principals are also developing new therapeutic materials for cancer treatment, personnel are developing immobilizing radionuclides for therapy and diagnostics, encapsulating therapeutics, biologics, or traceable markers into micro- and nano-dimensioned carriers such as microspheres, microfibers or nano-spheres. The company holds a special radiation license for their Radioactive Materials Processing Facility under the direction of the firm's internationally respected health physicists. Products in development and in-vitro and in-vivo evaluations include radioactive microspheres/nano-spheres and radiological devices for various soft tissue tumors and targeted cancer therapies. In sum, the firm's products are Radioactive Glass Microspheres for Radiation Therapy; Bioactive Glass Microspheres, Fibers and Powders; High Silica and Alkali-Free Microspheres; and Metal or Metal Coated Microspheres.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2022 2 NIH $3,977,533
Project Title: PET Enabled Microspheres for Radioembolization of Liver Tumors
2016 2 NIH $1,753,720
Project Title: Radioactive Stents for Brachytherapy of Esophageal Cancers
2013 1 NIH $182,131
Project Title: Molecularly Engineered Biomaterials For Minimally Invasive Dental Treatment
2008 1 NIH $140,370
Project Title: Nano Radioisotope Sources For Targeted Radiation Therapy
2008 2 NIH $939,180
Project Title: Absorbable and Low-Cost Radioseeds for Malignant Tumors

Key People / Management

  Yongren (Ben) Peng Sr -- President

Company News

There are no news available.